PDF
DataM
North America Diagnostic Imaging Market Report
SKU: MI7615

North America Diagnostic Imaging Market Size, Share, Industry, Forecast and Outlook (2024-2031)

North America Diagnostic Imaging Market is segmented By Type (X-Ray, MRI, SPECT Imaging, Ultrasound, Computed Tomography, Tactile Imaging, Functional Near Infrared Spectroscopy, Others), By Application (Orthopedic, Neurology, Oncology, Cardiology, Others), By End User (Hospitals, Diagnostics Centers, Others) 

Last Updated: || Author: Rohan Sawant || Reviewed: Akshay Reddy

Market Size & Forecast
Competitive Analysis
Partner Identification
Unmet Needs
Regulatory Compliance
Opportunity Analysis

Stop Guessing and Start Converting. 81% of our Clients purchase reports tailored to their exact business goals.

Report Summary
Table of Contents
List of Tables & Figures

North America Diagnostic Imaging Overview

North America Diagnostic Imaging Market reached US$ 9.7 billion in 2023 and is expected to reach US$ 14.09 billion by 2031, growing at a CAGR of 5.2% during the forecast period 2024-2031.

Diagnostic imaging refers to a range of techniques used to visualize the internal structures of the body to identify the causes of illness or injury and to confirm diagnoses. It also helps doctors assess how effectively a patient’s body is responding to treatment for conditions such as fractures or diseases. 

Diagnostic imaging includes MRI, MRA scans, CT scans, ultrasound, bone density scans, mammography, X-rays, arthrograms, and myelograms. Diagnostic imaging technology plays an important role in diagnosing the disease condition and also in analyzing the abnormalities of the therapies.

Market Scope

MetricsDetails
CAGR5.2%
Market Size Available for Years2022-2031
Estimation Forecast Period2024-2031
Revenue UnitsValue (US$ Mn) 
Segments CoveredType, Application, End-User
Report Insights CoveredCompetitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.

                                                                          For more details on this report – Request for Sample

Market Dynamics: Drivers & Restraints

Rising geriatric population 

The growing elderly population in North America is a crucial driving factor in the Diagnostic Imaging Market's growth. With rising age, age-related chronic diseases and ailments, emphasize the need for a more comprehensive diagnostic imaging solution for early detection, precise diagnosis, and continued monitoring. 

Cancer, cardiovascular disease, and osteoarthritis have grown increasingly important among the elderly, emphasizing the need for different diagnostics such as X-rays, MRIs, and CT scans. This transition has increased market demand for diagnostic imaging services. Healthcare providers are constantly investing in improved imaging technology to cater to this growing generation, fueling market development. 

As a result, the diagnostic imaging market in North America is not only adjusting to a changing healthcare environment, but it is also playing a crucial role in meeting the healthcare demands of an aging population while expanding market share.

High costs of the equipment

High costs of the diagnostic imaging equipment such as MRI, PET scan, CT scans could restrict many clinics and hospitals from adopting them due to their lower budgets. The hospitals and clinics in the middle-income and lower income countries choose the diagnostic equipment that suits their budget. This could show an overall impct on the market expansion. 

North America Diagnostic Imaging Segment Analysis

The North America diagnostic imaging market is segmented based on type, application, and end-user.

MRI segment is expected to dominate the market share

MRI segment is expected to hold a significant portion of the market share. This is due to their versatility in producing detailed images of the organs, and the technological advancements in product innovations. 

Magnetic resonance imaging (MRI) is a medical imaging technology that employs a magnetic field and computer-generated radio waves to produce detailed images of the tissues and organs in the body. MRI can image a variety of tissues and organs, including the brain, spine, joints, and internal organs. 

Its versatility makes it an important diagnostic tool for a wide range of medical specialties. MRI is particularly beneficial at detecting early changes in tissue and organ structure, allowing for earlier identification of diseases like cancers, neurological problems, and musculoskeletal diseases. The technological advancements in new product innovation and also the rise in number of launches of advanced MRI systems could drive the segment’s growth. 

For instance, on july 16, 2024, Fujifilm Healthcare Americas Corporation launched APERTO Lucent, a powerful open 0.4T MRI system in the U.S.. The wide, laterally moving table complements the system’s open architecture to offer a comfortable patient experience. 

Segmentation

By Type

  • MRI
  • SPECT Imaging
  • X-Ray
  • Ultrasound
  • Computed Tomography
  • Tactile Imaging
  • Functional Near Infrared Spectroscopy
  • Others 

By Application

  • Orthopedic
  • Neurology
  • Oncology
  • Cardiology
  • Others

By End-User

  • Hospitals
  • Diagnostic Centers
  • Others

North America Diagnostic Imaging Competitive Landscape

The major players in the market include FUJIFILM Healthcare Americas Corporation, Hitachi Medical Corporation, Hologic Inc., Philips Healthcare, GE Healthcare, Canon Medical Systems USA, Inc., Samsung Medison America Inc., Mindray North America, Butterfly Network, Inc. and Siemens Healthineers USA among others.

Why Purchase the Report?

  • To visualize the North America diagnostic imaging market segmentation based on type, application, end-user, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of diagnostic imaging market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The North America diagnostic imaging market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2026

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
FAQ’s

  • The North America Diagnostic Imaging Market reached US$ 9.7 billion in 2023 and is expected to grow to US$ 14.09 billion by 2031, expanding at a CAGR of 5.2% during the forecast period 2024–2031.

  • Growth is driven by a rising geriatric population, increasing prevalence of chronic diseases, advanced healthcare infrastructure, and continuous technological innovations in diagnostic imaging modalities.

  • Key imaging modalities include MRI, SPECT imaging, X-Ray, Ultrasound, Computed Tomography (CT), tactile imaging, and functional near-infrared spectroscopy, reflecting the broad use of various diagnostic technologies.

  • Primary end users are hospitals, diagnostic centers, and others, with hospitals typically representing the largest segment due to comprehensive diagnostic services.

  • Major competitors include FUJIFILM Healthcare Americas Corporation, Hitachi Medical Corporation, Hologic Inc., Philips Healthcare, GE Healthcare, Canon Medical Systems USA, Samsung Medison America, Mindray North America, Butterfly Network, and Siemens Healthineers USA.
PDF
DataM
North America Diagnostic Imaging Market Report
SKU: MI7615

Data-Backed Decisions Start Here

Explore how our research empowers industry leaders to cut through uncertainty. Get a free sample of this report or tailor it precisely to your business needs.

ISO 27001 Certified
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
Related Reports